tetano
Editor, Senior Moderator
J Virol
. 2026 Apr 6:e0028226.
doi: 10.1128/jvi.00282-26. Online ahead of print.
Q1020R in the spike proteins of MERS-CoV from Arabian camels confers resistance against soluble human DPP4
Nianzhen Chen[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Hannah Kleine-Weber[SUP] #[/SUP][SUP] 1 2 [/SUP], Khaled Alkharsah[SUP] 4 [/SUP], Michael Winkler[SUP] 1 [/SUP], Asisa Volz[SUP] 5 6 [/SUP], Marcel A Müller[SUP] 7 8 [/SUP], Victor M Corman[SUP] 7 8 9 [/SUP], Christian Drosten[SUP] 7 8 [/SUP], Markus Hoffmann[SUP] 1 [/SUP], Stefan Pöhlmann[SUP] 1 2 10 [/SUP]
Affiliations
The Middle East respiratory syndrome coronavirus (MERS-CoV) is a pre-pandemic coronavirus that is transmitted from camels, the natural reservoir, to humans and can cause severe disease. MERS cases have been documented in Arabia but not Africa, although the virus is circulating in both Arabian and African camels. Further, evidence has been provided that viruses in African camels might have a reduced capacity to cause disease. However, the underlying determinants are incompletely understood. Here, employing pseudotyped particles as model systems for MERS-CoV entry into cells, we compared cell entry of viruses from African and Arabian camels and its inhibition. We show that viruses found in Arabian camels and recent human cases are less susceptible to inhibition by human soluble DPP4 (sDPP4) than viruses from African camels, although both enter human cells efficiently and are comparably sensitive to inhibition by interferon-induced transmembrane (IFITM) proteins and neutralizing antibodies. Furthermore, relative resistance to sDPP4 was linked to mutation Q1020R, present in the spike proteins of recent Arabian but not African viruses. Finally, indirect evidence was obtained that sDPP4 in human plasma can inhibit MERS-CoV cell entry. These results support the concept that soluble DPP4 might constitute a natural barrier against human infection that is more efficiently overcome by viruses currently circulating in Arabian camels than those in African camels.IMPORTANCEMiddle East respiratory syndrome coronavirus (MERS-CoV) is an emerging virus that can cause severe lung disease, MERS, and is transmitted from camels to humans. Although MERS-CoV infects camels in both Africa and Arabia, MERS cases have only been documented in Arabia for reasons that remain incompletely understood. Here, we provide evidence that viruses recently circulating in Arabian camels and causing human infections are less susceptible to inhibition by human soluble DPP4 (sDPP4)-a secreted version of the viral receptor that is present in various bodily fluids. Furthermore, we link sDPP4 resistance to mutation Q1020R in the spike protein of these viruses. These results suggest that viruses currently circulating in Arabian camels are better equipped to overcome a natural barrier to infection, sDPP4, than those circulating in African camels.
Keywords: DPP4; Middle East respiratory syndrome; soluble DPP4; spike.
. 2026 Apr 6:e0028226.
doi: 10.1128/jvi.00282-26. Online ahead of print.
Q1020R in the spike proteins of MERS-CoV from Arabian camels confers resistance against soluble human DPP4
Nianzhen Chen[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Hannah Kleine-Weber[SUP] #[/SUP][SUP] 1 2 [/SUP], Khaled Alkharsah[SUP] 4 [/SUP], Michael Winkler[SUP] 1 [/SUP], Asisa Volz[SUP] 5 6 [/SUP], Marcel A Müller[SUP] 7 8 [/SUP], Victor M Corman[SUP] 7 8 9 [/SUP], Christian Drosten[SUP] 7 8 [/SUP], Markus Hoffmann[SUP] 1 [/SUP], Stefan Pöhlmann[SUP] 1 2 10 [/SUP]
Affiliations
- PMID: 41940670
- DOI: 10.1128/jvi.00282-26
The Middle East respiratory syndrome coronavirus (MERS-CoV) is a pre-pandemic coronavirus that is transmitted from camels, the natural reservoir, to humans and can cause severe disease. MERS cases have been documented in Arabia but not Africa, although the virus is circulating in both Arabian and African camels. Further, evidence has been provided that viruses in African camels might have a reduced capacity to cause disease. However, the underlying determinants are incompletely understood. Here, employing pseudotyped particles as model systems for MERS-CoV entry into cells, we compared cell entry of viruses from African and Arabian camels and its inhibition. We show that viruses found in Arabian camels and recent human cases are less susceptible to inhibition by human soluble DPP4 (sDPP4) than viruses from African camels, although both enter human cells efficiently and are comparably sensitive to inhibition by interferon-induced transmembrane (IFITM) proteins and neutralizing antibodies. Furthermore, relative resistance to sDPP4 was linked to mutation Q1020R, present in the spike proteins of recent Arabian but not African viruses. Finally, indirect evidence was obtained that sDPP4 in human plasma can inhibit MERS-CoV cell entry. These results support the concept that soluble DPP4 might constitute a natural barrier against human infection that is more efficiently overcome by viruses currently circulating in Arabian camels than those in African camels.IMPORTANCEMiddle East respiratory syndrome coronavirus (MERS-CoV) is an emerging virus that can cause severe lung disease, MERS, and is transmitted from camels to humans. Although MERS-CoV infects camels in both Africa and Arabia, MERS cases have only been documented in Arabia for reasons that remain incompletely understood. Here, we provide evidence that viruses recently circulating in Arabian camels and causing human infections are less susceptible to inhibition by human soluble DPP4 (sDPP4)-a secreted version of the viral receptor that is present in various bodily fluids. Furthermore, we link sDPP4 resistance to mutation Q1020R in the spike protein of these viruses. These results suggest that viruses currently circulating in Arabian camels are better equipped to overcome a natural barrier to infection, sDPP4, than those circulating in African camels.
Keywords: DPP4; Middle East respiratory syndrome; soluble DPP4; spike.